http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2375063-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9715ee42ca04792255166d73b4f79385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0838410468c0fedb8db2e20f44a91ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d2536d25c606cf230e24d4f94045e92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80ea52df622383c2e8bba7e16c3787e7 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
filingDate | 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1338a75ff5c2302b560e1125a5c5dac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7485b849b8dcc9a76ca71f3dc0921ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf04c6ebac4d7fa78f606ad43241bee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66dd8a5da5c95f07787d0b91a8944740 |
publicationDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2375063-C1 |
titleOfInvention | Method of estimating efficiency of neoadjuvant autohemochemotherapy in patients suffering from carcinoma of cervival stump |
abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, namely oncology and can be used in estimation of clinical effectiveness factors in treatment of carcinoma of cervical stump. Daily urine is analysed for estradiol content and if decreased after treatment from initial level within 8.44-12.85 nmol/days, positive antineoplastic effect of treatment is stated, and if urine estradiol content is maintained in the treated patients within 8.81-11.38 nmol/days, the absence of antineoplastic effect is stated. The obtained results allow considering dynamics of estradiol content in daily urine of the patients suffering from carcinoma of cervical stump prior to AHCT as an additional laboratory test to estimate efficiency of presented pharmacotherapy. Observed positive clinical effect is confirmed by higher operability and improved life quality of the patients. n EFFECT: estimation of hormonal index earlier not detected to estimate clinical effectiveness of antineoplastic therapy. n 1 tbl, 2 ex |
priorityDate | 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.